AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

HIV-1 Tat vaccine protects against SHIV89.6P replication in monkeys.

Vaccine Weekly

| December 01, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 DEC 1 - (NewsRx.com & NewsRx.net) -- HIV-1 Tat vaccinated cynomolgus monkeys were protected against SHIV89.6P replication.

According to a study from Italy, "Vaccination with a biologically active Tat protein or tat DNA contained infection with the highly pathogenic SHIV89.6P virus, preventing CD4 T-cell decline and disease onset. Here we show that protection was prolonged, since neither CD4 T-cell decline nor active virus replication was observed in all vaccinated animals that controlled virus replication up to week 104 after the challenge. In contrast, virus persisted and replicated in peripheral blood mononuclear cells and lymph nodes of infected animals, two of which died."

"Tat-specific antibody, CD4 and CD8 T-cell responses were high and stable only in the animals controlling the infection," said Maria Teresa Maggiorella at the Istituto Superiore di Sanita in Rome and collaborators in Italy and the Netherlands. "In contrast, Gag-specific antibody production and CD4 and CD8 T-cell responses were consistently and persistently positive only in the monkeys that did not control primary virus replication."

Maggiorella and her associates concluded, ...

Related articles from newspapers, magazines, journals, and more
STMicroelectronics and Istituto Superiore Mario Boella Team Up to Overcome...
Press release article from: PR Newswire June 22, 2007 700+ words
...Center. The center, for cooperation between ST and the Istituto Superiore Mario Boella (ISMB), will focus its efforts on performing...automotive products in safety and reliability." About Istituto Superiore Mario Boella (ISMB) Founded in July 2000 by the Compagnia...
Publication No. WO/2009/112289 Published on Sept. 17, Assigned to Istituto...
News wire article from: US Fed News Service, Including US State News November 12, 2009 700+ words
...Garaci, all from Italy, have developed a cellular differentiation promotion. The patent has been assigned to Istituto Superiore di Sanita, Roma, Italy. According to an abstract posted by the World Intellectual Property Organization...
Patent No. 7,566,568 Issued on July 28, Assigned to Istituto Superiore di...
News wire article from: US Fed News Service, Including US State News August 1, 2009 700+ words
...cells. The inventors were issued U.S. Patent No. 7,566,568 on July 28. The patent has been assigned to Istituto Superiore di Sanita, Rome. According to the description released by the U.S. Patent & Trademark Office: "The...
Publication No. WO/2009/106372 Published on Sept. 3, Assigned to ISTITUTO...
News wire article from: US Fed News Service, Including US State News September 5, 2009 700+ words
...Foa' and Marco Tartaglia, both of Italy, have developed a diagnostic method. The patent has been assigned to ISTITUTO SUPERIORE DI SANATA, Roma, Italy. According to an abstract posted by the World Intellectual Property Organization, the...
Vaginal infection with influenza A elicits immune response to HIV epitope.
Newspaper article from: Vaccine Weekly March 10, 2004 700+ words
...collaborators at the Istituto Superiore di Sanita in Italy...Laboratory of Virology, Istituto Superiore di Sanita, Viale...was prepared by Vaccine Weekly editors from staff...Copyright 2004, Vaccine Weekly via NewsRx.com...
Gamma-herpesvirus 68 protects IFN receptor knockout mice from infection.
Newspaper article from: Vaccine Weekly June 16, 2004 700+ words
...collaborators at the Istituto Superiore di Sanita in Italy...Laboratory of Virology, Istituto Superiore di Sanita, Viale...was prepared by Vaccine Weekly editors from staff...Copyright 2004, Vaccine Weekly via NewsRx.com...
Anti-idiotypic antibody fragment effective against candidiasis.
Newspaper article from: Vaccine Weekly January 7, 2004 700+ words
...Polonelli and collaborators at the Istituto Superiore di Sanita, Universita degli...Immune-Mediated Diseases, Istituto Superiore di Sanita, Viale Regina Elena...This article was prepared by Vaccine Weekly editors from staff and other...
Glucans play a role in protection against yeast infections.
Newspaper article from: Vaccine Weekly December 11, 2002 700+ words
...Bromuro and colleagues at the Istituto Superiore di Sanita in Rome and the...Bacteriology and Medical Mycology, Istituto Superiore di Sanita, V. le Regina...This article was prepared by Vaccine Weekly editors from staff and other...
For more facts and information, see all results

Source: HighBeam Research, HIV-1 Tat vaccine protects against SHIV89.6P replication in monkeys.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA